GE Healthcare
The medtech giant signed a contract with BARDA to devise AI-enabled ultrasound technology that helps clinicians triage and diagnose lung pathology and traumatic injury.
The funds will be used to develop AI-enabled ultrasound technology for maternal care and pediatric lung health in low- and middle-income countries.
The pair will work to further the practice of radiology and patient care using innovation, such as theranostics, AI and digital health platforms.
The algorithm helps predict missed appointments, failure to schedule follow-up visits and late arrivals.
The smartphone-sized device offers continuous monitoring of respiration rate while allowing patient mobility.
The health tech giant reported $4.8 billion in revenue, a 7% growth year-over-year, and increased profit expectations for 2023.
The company's Precision DL speeds up screening time, enhances the image quality of PET/CT scans and improves small lesion detection.
The newly independent company reported $372 million in net income with revenue of $4.7 billion, an 8% increase year-over-year.
The deal marks GE HealthCare's second announced acquisition since it debuted as an independent company early this year.
The newly spun-off GE HealthCare entered into an agreement to acquire IMACTIS, developer of CT interventional guidance technology.